Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.37 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.31 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29695439 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1DPP4PDCD1CD274 | |
| Phosphine SCHEMBL29173742 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1DPP4PDCD1CD274 | |
| Lithium SCHEMBL29695298 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1DPP4PDCD1CD274 | |
| Potassium SCHEMBL30843013 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1DPP4PDCD1CD274 | |
| Bromide SCHEMBL30945893 | 0.96 | CYP3A4 (0.35) | CYP3A4TDP1DPP4PDCD1CD274 | |
| SCHEMBL19002943 | 0.92 | DPP4 (0.32) | CYP3A4TDP1DPP4PTGER1PTGER4 | |
| SCHEMBL30945894 | 0.92 | DPP4 (0.32) | CYP3A4TDP1DPP4 | |
| SCHEMBL8522187 | 0.89 | DPP4 (0.52) | DPP4PDCD1CD274KMT2APTGER1 | |
| SCHEMBL8056033 | 0.88 | PTGS2 (0.33) | CYP3A4TDP1DPP4 | |
| SCHEMBL8029937 | 0.88 | FFAR1 (0.38) | CYP3A4TDP1PDCD1CD274KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115141090-B | Preparation method of enal | 中国石油化工股份有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-113087601-B | Fischer-Tropsch olefin-based high-carbon ether preparation method and high-carbon ether phase change material | 内蒙古伊泰煤基新材料研究院有限公司 | 2023-12-26 | — | — | CN | claimed |
| US-20230133133-A1 | ALDEHYDE GENERATION VIA ALKENE HYDROFORMYLATION | NORTH CAROLINA STATE UNIVERSITY | 2023-05-04 | — | — | US | claimed |
| EP-4121406-A1 | ALDEHYDE GENERATION VIA ALKENE HYDROFORMYLATION | North Carolina State University (US) | 2023-01-25 | — | — | EP | claimed |
| CN-115443261-A | Aldehyde formation via hydroformylation of olefins | 北卡罗莱纳州立大学 | 2022-12-06 | — | — | CN | claimed |
| CN-115141090-A | Preparation method of olefine aldehyde | 中国石油化工股份有限公司 | 2022-10-04 | — | — | CN | claimed |
| WO-2021188940-A1 | ALDEHYDE GENERATION VIA ALKENE HYDROFORMYLATION | NORTH CAROLINA STATE UNIVERSITY (US) | 2021-09-23 | — | — | WO | claimed |
| EP-3699167-A1 | PROCESS FOR PREPARING METHYL 1-BENZOSUBERONE-7-CARBOXYLATE | Sanofi (FR) | 2020-08-26 | — | — | EP | claimed |
| US-20030119923-A1 | Method for recovering rhodium from reaction products of oxosynthesis | OXEA GMBH (DE) | 2003-06-26 | — | — | US | claimed |
| US-6051743-A | Process for the preparation of predominantly unbranched higher primary alcohols | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-04-18 | — | — | US | claimed |
| EP-0311619-B1 | CHELATE LIGANDS FOR LOW PRESSURE HYDROFORMYLATION CATALYST AND PROCESS EMPLOYING SAME | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1991-03-06 | — | — | EP | claimed |
| WO-1990006295-A1 | PREPARATION OF BIARYL COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1990-06-14 | — | — | WO | claimed |
| EP-0366573-A1 | Preparation of biaryl compounds | EASTMAN CHEMICAL COMPANY (US) | 1990-05-02 | — | — | EP | claimed |
| US-4912276-A | Preparation of biaryl compounds | EASTMAN KODAK COMPANY (US) | 1990-03-27 | — | — | US | claimed |
| US-4904808-A | Chelate ligands for low pressure hydroformylation catalyst and process employing same | EASTMAN KODAK COMPANY (US) | 1990-02-27 | — | — | US | claimed |
| US-4851581-A | PHOSPHINO COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1989-07-25 | — | — | US | claimed |
| EP-0311619-A1 | CHELATE LIGANDS FOR LOW PRESSURE HYDROFORMYLATION CATALYST AND PROCESS EMPLOYING SAME. | EASTMAN KODAK CO (US) | 1989-04-19 | — | — | EP | claimed |
| US-4742178-A | RHODIUM COMPLEX CATALYST | EASTMAN KODAK COMPANY (US) | 1988-05-03 | — | — | US | claimed |
| WO-1987007600-A2 | CHELATE LIGANDS FOR LOW PRESSURE HYDROFORMYLATION CATALYST AND PROCESS EMPLOYING SAME | EASTMAN KODAK COMPANY (US) | 1987-12-17 | — | — | WO | claimed |
| US-4694109-A | Chelate ligands for low pressure hydroformylation catalyst and process employing same | EASTMAN KODAK COMPANY (US) | 1987-09-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133133-A1 | ALDEHYDE GENERATION VIA ALKENE HYDROFORMYLATION | HAO2, ALDH3A1, ALDH2 | CYP3A4 120/4885TDP1 4072/4885DPP4 4652/4885 |
| US-20030119923-A1 | Method for recovering rhodium from reaction products of oxosynthesis | NUDT1, OXGR1, HAO2 | CYP3A4 269/4885TDP1 1036/4885DPP4 3274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.